Novo Nordisk Will Soon Reveal Whether Its GLP-1 Drug Can Slow Alzheimer's

Novo's upcoming Alzheimer's trial results will test whether Rybelsus can slow cognitive decline and reshape treatment ...
The American Journal of Managed Care

How Effective and Safe Are GLP-1s for Weight Loss?

GLP-1 RAs, particularly semaglutide and tirzepatide, outperform older medications in achieving significant weight loss in adults with and without type 2 diabetes. Semaglutide and tirzepatide met ...

Why Big Pharma Won't Quit the Diet. Who Will Win the Next Weight Loss Battle?

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish ...

Weight loss drugs in India: Are we using them correctly? Here are some misconceptions

These drugs must be started only after a full medical evaluation, used strictly under medical supervision and avoided ...

5 new weight-loss drugs to watch in the fight for the next Ozempic

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
Public News Service on MSN

MS Medicaid patients face hurdles to getting weight loss drugs

By Phil Galewitz for KFF Health News. Broadcast version by Trimmel Gomes for Mississippi News Connection reporting for the ...

High-stakes Novo Nordisk Alzheimer's studies could yield answers on GLP-1 benefit

Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...